DCF — THE HORSHAM CLINIC
Enterprise Value: $1.2M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$1.2M
Enterprise Value
$-1.3M
PV of Cash Flows
$2.5M
PV of Terminal Value
$4.0M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $65.7M | $1.7M | 3.0% | $-1.1M | $-1.0M |
| Year 2 | $67.7M | $2.4M | 4.0% | $-0.6M | $-0.5M |
| Year 3 | $69.7M | $3.2M | 5.0% | $-0.1M | $-0.1M |
| Year 4 | $71.8M | $3.7M | 5.0% | $0.1M | $0.1M |
| Year 5 | $73.9M | $3.9M | 5.0% | $0.3M | $0.2M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $1.2M. Terminal value accounts for 212% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$63.8M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base0.020884898695184454
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5